Antibody Drug Conjugates Global Market Report 2023

Feb 2023| TBR1580C| TBRC (Publisher)

Sample Report

Report Highlights

Including: 1) By Type: Monoclonal Antibodies; Linker; Drug/Toxin
2) By Application: Blood Cancer; Breast Cancer; Ovarian Cancer; Lung Cancer; Brain Tumor
3) By Product: Adcertis; Kadcyla
4) By Technology: Immunogen Technology; Seattle Genetics Technology; Immunomedics Technology
5) By End User: Hospital; Clinics
Covering: Bayer AG; Concortis Biotherapeutics; F. Hoffman-La Roche Ltd.; ImmunomedicsInc.; Oxford BioTherapeutics

Antibody Drug Conjugates Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antibody drug conjugates market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:
Where is the largest and fastest growing market for antibody drug conjugates ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antibody drug conjugates market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Report Synopsis

Report Metrics	Details
Base year considered	2022
Forecast period considered	2022-2032
Units considered	$ Billion
Segments covered	By Type, By Application, By Product, By Technology, By End User
Industry covered	Pharmaceuticals
Regions covered	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Countries covered	Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
Companies studied	Bayer AG Pfizer Inc. Concortis Biotherapeutics F. Hoffman-La Roche Ltd. ImmunomedicsInc. Oxford BioTherapeutics Seattle Genetics Inc. Astellas Pharma/Agensys Takeda Pharmaceutical Company Limited Abbvie Inc. Oxford BioTherapeutics AgensysInc. Antikor Celldex Therapeutics Genentech Heidelberg Pharma Immunomedics Roche Holding Ag Mersana Therapeutics Millennium Pharmaceuticals Progenics Pharmaceuticals Synthon

Scope

Markets Covered:

By Type: Monoclonal Antibodies; Linker; Drug/Toxin; Other Types
By Application: Blood Cancer; Breast Cancer; Ovarian Cancer; Lung Cancer; Brain Tumor; Other Applications
By Product: Adcertis; Kadcyla; Other Products
By Technology: Immunogen Technology; Seattle Genetics Technology; Immunomedics Technology; Other Technology
By End User: Hospital; Clinics; Other End Users

Companies Mentioned: Bayer AG; Concortis Biotherapeutics; F. Hoffman-La Roche Ltd.; ImmunomedicsInc.; Oxford BioTherapeutics

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Table 1 : Global Historic Market Growth, 2017-2022, $ Billion
Table 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Table 3 : Global Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 4 : Global Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 5 : Global Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 6 : Global Antibody Drug Conjugates Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 7 : Global Antibody Drug Conjugates Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 8 : Global Antibody Drug Conjugates Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 9 : Global Antibody Drug Conjugates Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 10 : Asia-Pacific, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 11 : Asia-Pacific, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 12 : Asia-Pacific, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 13 : China, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 14 : China, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 15 : China, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 16 : India, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 17 : India, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 18 : India, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 19 : Japan, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 20 : Japan, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 21 : Japan, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 22 : Australia, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 23 : Australia, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 24 : Australia, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 25 : Indonesia, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 26 : Indonesia, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 27 : Indonesia, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 28 : South Korea, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 29 : South Korea, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 30 : South Korea, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 31 : Western Europe, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 32 : Western Europe, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 33 : Western Europe, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 34 : UK, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 35 : UK, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 36 : UK, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 37 : Germany, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 38 : Germany, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 39 : Germany, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 40 : France, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 41 : France, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 42 : France, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 43 : Eastern Europe, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 44 : Eastern Europe, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 45 : Eastern Europe, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 46 : Russia, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 47 : Russia, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 48 : Russia, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 49 : North America, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 50 : North America, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 51 : North America, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 52 : USA, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 53 : USA, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 54 : USA, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 55 : South America, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 56 : South America, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 57 : South America, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 58 : Brazil, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 59 : Brazil, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 60 : Brazil, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 61 : Middle East, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 62 : Middle East, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 63 : Middle East, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 64 : Africa, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 65 : Africa, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 66 : Africa, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 67 : Bayer AG Financial Performance
Table 68 : Concortis Biotherapeutics Financial Performance
Table 69 : F. Hoffman-La Roche Ltd. Financial Performance
Table 70 : Immunomedics, Inc. Financial Performance
Table 71 : Oxford BioTherapeutics Financial Performance

Figure 1 : Global Historic Market Growth, 2017-2022, $ Billion
Figure 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Figure 3 : Global Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 4 : Global Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 5 : Global Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 6 : Global Antibody Drug Conjugates Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 7 : Global Antibody Drug Conjugates Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 8 : Global Antibody Drug Conjugates Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 9 : Global Antibody Drug Conjugates Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 10 : Asia-Pacific, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 11 : Asia-Pacific, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 12 : Asia-Pacific, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 13 : China, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 14 : China, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 15 : China, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 16 : India, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 17 : India, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 18 : India, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 19 : Japan, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 20 : Japan, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 21 : Japan, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 22 : Australia, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 23 : Australia, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 24 : Australia, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 25 : Indonesia, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 26 : Indonesia, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 27 : Indonesia, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 28 : South Korea, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 29 : South Korea, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 30 : South Korea, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 31 : Western Europe, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 32 : Western Europe, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 33 : Western Europe, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 34 : UK, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 35 : UK, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 36 : UK, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 37 : Germany, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 38 : Germany, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 39 : Germany, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 40 : France, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 41 : France, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 42 : France, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 43 : Eastern Europe, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 44 : Eastern Europe, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 45 : Eastern Europe, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 46 : Russia, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 47 : Russia, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 48 : Russia, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 49 : North America, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 50 : North America, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 51 : North America, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 52 : USA, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 53 : USA, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 54 : USA, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 55 : South America, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 56 : South America, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 57 : South America, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 58 : Brazil, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 59 : Brazil, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 60 : Brazil, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 61 : Middle East, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 62 : Middle East, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 63 : Middle East, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 64 : Africa, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 65 : Africa, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 66 : Africa, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 67 : Bayer AG Financial Performance
Figure 68 : Concortis Biotherapeutics Financial Performance
Figure 69 : F. Hoffman-La Roche Ltd. Financial Performance
Figure 70 : Immunomedics, Inc. Financial Performance
Figure 71 : Oxford BioTherapeutics Financial Performance

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

Antibody Drug Conjugates Global Market Report 2022

Published Date - Mar 2022
Report Code - TBR1580B

Including: 1) By Type: Monoclonal Antibodies; Linker; Drug/Toxin; Others
2) By Application: Blood Cancer; Breast Cancer; Ovarian Cancer; Lung Cancer; Brain Tumor; Others
3) By Product: Adcertis; Kadcyla; Others
4) By Technology: Immunogen Technology; Seattle Genetics Technology; Immunomedics Technology; Others
5) By End User: Hospital; Clinics; Others
Covering: Bayer AG; Concortis Biotherapeutics; F.Hoffman-La Roche Ltd.; Immunomedics ...

Antibody Drug Conjugates Global Market Report 2021: COVID-19 Growth And Change To 2030

Published Date - Sep 2021
Report Code - TBR1580A

Antibody Drug Conjugates Global Market Report 2023

Report Highlights

Report Synopsis

Antibody Drug Conjugates Global Market Report 2022

Antibody Drug Conjugates Global Market Report 2021: COVID-19 Growth And Change To 2030

FAQ